Oregon Department of Consumer and Business Services, Insurance Regulation

Rule Rule 836-200-0520
Threshold for Reporting New Specialty Drug

Beginning March 15, 2019, 30 days or less after a manufacturer introduces a new prescription drug for sale in the United States at a price for a 30 day supply or for a course of treatment lasting less than one month that exceeds the threshold established by the Centers for Medicare and Medicaid Services for specialty drugs in the Medicare Part D program, the manufacturer must report to the department the information described in OAR 836-200-0530 (Form and Manner Requirements for Drug Pricing Reporting) (4).

Last accessed
Jun. 8, 2021